Diagnostic value of serum KL-6 and IL-6 levels in critically ill patients with COVID-19-associated pneumoniaCorrespondence Published on 2022-08-012022-10-05 Journal: The Journal of Infection [Category] 바이오마커, 진단, [키워드] COVID-19 Critically ill patient IL-6 level interleukin-6 Krebs von den Lungen-6 Mortality Pneumonia SARS-CoV-2 serum [DOI] 10.1016/j.jinf.2022.08.016 [Article Type] Correspondence
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600IIKrebs von den Lungen-6, COVID-19 환자의 질병 심각도 지표: Lumipulse G600II와 비교한 Tosoh AIA-360의 분석 검증 및 품질 평가Article Published on 2022-02-152022-09-10 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), MERS, SARS, 바이오마커, 치료기술, [키워드] an area analysed Analysis analytical validation article assessment AUC AUROC best Biomarker chemiluminescence comparable Concentration concentrations COVID COVID-19 COVID-19 patient COVID-19 patients cut-off value demonstrated detectable disease severity effective enzyme enzyme immunoassay evaluated fluorescent Fujirebio Hospitalized identify immunoassay interstitial pneumonia IQR Krebs von den Lungen-6 limit marker material median age non-severe patient non-severe patients Patient Quality reagent receiver reported Research ROC serum severe COVID-19 patients Siena significantly higher unit verification was measured [DOI] 10.3390/ijerph19042176 PMC 바로가기 [Article Type] Article
Analysis of Early Biomarkers Associated with the Development of Critical Respiratory Failure in Coronavirus Disease 2019 (COVID-19)Article Published on 2022-01-282022-10-31 Journal: Diagnostics [Category] COVID-19, [키워드] acute respiratory distress Admission Analysis analyzed association Biomarker C-reactive protein Concentration consecutive patient coronavirus disease COVID-19 COVID-19 patients Cox proportional hazard CRP d -dimer death development elevated failure high-mobility group box-1 protein hospital IL-6 independent Inflammatory cytokine inflammatory mediator Injury interleukin-6 Krebs von den Lungen-6 mechanical ventilation Multivariate analysis outcome Platelet predict Protein receiver operating characteristic regression analysis reported respiratory Respiratory failure syndrome type II pneumocytes Ventilation [DOI] 10.3390/diagnostics12020339 PMC 바로가기 [Article Type] Article
Clinical relevance of serum Krebs von den Lungen-6 levels in patients with coronavirus disease 2019코로나 바이러스 질병 환자의 혈청 Krebs von den Lungen-6 수준의 임상 적 관련성 2019Article Published on 2021-12-012022-08-31 Journal: Cytokine [Category] SARS, 바이오마커, [키워드] Admission clinical Clinical outcome clinical outcomes Comorbidities coronavirus coronavirus disease Coronavirus disease 2019 correlation cough COVID-19 Day defined demographic demographic data elevated enrolled evaluate fatigue Fever had more Hospital stay Hospitalization Hospitalized independent risk factor Indicator instance Krebs von den Lungen-6 laboratory parameter Laboratory parameter. Laboratory parameters nucleic acid on admission parameter Patient Prognosis reported serum severity and prognosis shown significantly statistically significant symptom onset Symptoms was measured were recorded wheezing [DOI] 10.1016/j.cyto.2021.155513 PMC 바로가기 [Article Type] Article
Serum Krebs von den Lungen-6 for Predicting the Severity of COVID-19 Lung Injury: A Systematic Review and Meta-AnalysisCovid-19 폐 손상의 중증도 예측을위한 혈청 Krebs von den Lungen-6 : 체계적인 검토 및 메타 분석Meta-Analysis Published on 2021-11-062022-08-31 Journal: Iranian Biomedical Journal [Category] MERS, 바이오마커, [키워드] 95% CI adult COVID-19 patients alveolar epithelium Analysis appear article Biomarker conducted COVID-19 COVID-19 patient COVID-19 patients eligibility criteria expressed glycoprotein Infectious disease Injury Krebs von den Lungen-6 library Lung injury NOS on type ProQuest reflected review screened sensitivity Sensitivity and specificity serum severe lung injury Severe patient severe patients severity significantly higher SMD specificity systematic review [DOI] 10.52547/ibj.25.6.381 PMC 바로가기 [Article Type] Meta-Analysis
Serum Krebs von den Lungen-6 levels are associated with mortality and severity in patients with coronavirus disease 2019혈청 Krebs von den Lungen-6 수준은 2019년 코로나바이러스 질환 환자의 사망률 및 중증도와 관련이 있습니다Article Published on 2021-09-012022-09-11 Journal: Respiratory investigation [Category] MERS, SARS, 바이오마커, [키워드] acute respiratory distress acute respiratory distress syndrome Admission an area analyzed ARDS arterial partial pressure of oxygen cardiovascular center coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 cutoff value determine disease disease severity enrolled fraction Hospitalized Japanese Krebs von den Lungen-6 medical record medical records Mortality negative correlation nonsurvivor nonsurvivors on admission outcome oxygen partial pressure Patient patients with COVID-19 Predictive Prognosis progressed reported respiratory Respiratory Center respiratory distress Respiratory distress syndrome sensitivity serum severe disease severity significantly specificity survivor syndrome the disease U/mL [DOI] 10.1016/j.resinv.2021.04.002 PMC 바로가기 [Article Type] Article
Correlation of Krebs von den Lungen-6 and fibronectin with pulmonary fibrosis in coronavirus disease 2019코로나바이러스 질병 2019에서 Krebs von den Lungen-6 및 fibronectin과 폐 섬유증의 상관 관계Article Published on 2021-06-012022-08-31 Journal: Clinica chimica acta; international journal of cli [Category] MERS, 바이오마커, [키워드] 113 patient 113 patients acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Admission C-reactive protein category caused Concentration control subjects coronavirus coronavirus disease Coronavirus disease 2019 correlated correlation COVID-19 COVID-19 case COVID-19 cases COVID-19 patient diagnosed disease severity early stage elevated enrolled Fibronectin fibrosis Hospital admission hospital discharge investigated Krebs von den Lungen-6 Lung injury lymphocyte Lymphocytes marker Mild moderate on admission outcome patients Phenotypes positively correlated pulmonary pulmonary fibrosis respiratory Retrospective study SARS-CoV-2 serum Severe case severe cases severe COVID-19 patients severe group severity significantly significantly higher tested the disease [DOI] 10.1016/j.cca.2021.02.012 PMC 바로가기 [Article Type] Article
Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patientsKrebs Von den Lungen-6은 COVID-19 환자에서 이차성 폐섬유증의 위험과 가역성에 대한 예측 지표입니다.Research Paper Published on 2021-04-102022-08-31 Journal: International Journal of Biological Sciences [Category] MERS, SARS, 바이오마커, 치료기술, [키워드] Analysis AUC clinical clinical information collected Coronavirus disease 2019 COVID-19 COVID-19 patient diagnose dysregulated immune response Efficacy evaluate fibrosis focus hospital Hospital stay immune response Inflammation information Krebs von den Lungen-6 lung Lung function marker moderate nucleic acid nucleic acid test Occurrence Patient predict Predictive pulmonary fibrosis radiological receiver operating characteristic recorded reflect risk ROC SARS-COV-2 infection severe group severity severity of COVID-19 severity of illness survival curve Survival curves [DOI] 10.7150/ijbs.58825 PMC 바로가기 [Article Type] Research Paper
Serum KL-6 level is a useful biomarker for evaluating the severity of coronavirus disease 2019혈청 KL-6 수준은 코로나바이러스 질병 2019의 중증도를 평가하는 데 유용한 바이오마커입니다Article Published on 2020-11-012022-08-31 Journal: Respiratory investigation [Category] MERS, 바이오마커, [키워드] Biomarker category center Characteristics Comorbidities coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 severity Critical cut-off cut-off value diagnosed with COVID-19 Diagnosis died disease disease severity elevated enrolled evaluate examined groups Infection Japanese Krebs von den Lungen-6 median Mild moderate non-severe group Older Patient peak level peak levels Pneumonia radiological receiver operating characteristic Red sensitivity serum severe COVID-19 severe group severe or critical illness severity severity of COVID-19 significantly significantly higher specificity to define two group two groups U/mL Viral viral infection was used were used worsened [DOI] 10.1016/j.resinv.2020.07.004 PMC 바로가기 [Article Type] Article